Loading…
← CockpitCompetitor Analysis › SMT.NS Sahajanand Medical Technologies LimitedOpen in the cockpit ↗

Sahajanand Medical Technologies LimitedSMT.NSCompetitor analysis, valuation and peers

India · INR·Pharma & Healthcare›Medical Specialties
Mkt cap
$595M
US dollars, full cap
$/day
$16.1M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
n/a
WACC 11.6%
Hurdle
n/a
no reverse DCF
Close · INR₹546.80
1D-0.4%
1W+9.8%
1Mn/a
3Mn/a
6Mn/a
YTDn/a
1Yn/a
ATR %8.3%
52w lowhigh5.5% off high

What Sahajanand Medical Technologies does

No business profile yet.

Sahajanand Medical Technologies at a glance

Size Sahajanand Medical Technologies (SMT.NS) is an India Health Care company (Medical Specialties) with a market value of $595M, the 788th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹546.80 on 18 Nov 2026.

Sahajanand Medical Technologies financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Total debt₹3.32Bn/an/an/an/a
Revenue growth—————

Quarterly statements and history in the cockpit →

Sahajanand Medical Technologies competitors and peer comparison

How Sahajanand Medical Technologies compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Sahajanand Medical Technologies against its 20 peers (data as of 18 Nov 2026)
MeasureSMT.NSPeer medianRank in peer set
Distance from 52-week high-5.5%-34.3%3rd highest of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Sahajanand Medical Technologies SMT.NSIndia$595Mn/an/an/an/an/an/a
vVARDIS VVVVUnited States$594Mn/a+148%-72%14.3×n/an/a
Sight Sciences SGHTUnited States$599M+122%+16%-30%6.4×n/an/a
Medistim MEDI.OLNorway$599M+32%+19%29%7.1×-1.2%+14.5%
Tactile Systems Technology TCMDUnited States$592M+6%+14%9%1.5×8.4%+12.0%
Nanosonics NAN.AXAustralia$599M-4%+3%7%3.8×35.3%+6.7%
Hangzhou AGS MedTech 688581.SSChina$590M-22%-18%33%3.7×0.4%+27.8%
Ningbo David Medical Device 300314.SZChina$589M+25%+19%11%5.4×n/an/a
Orchestra BioMed OBIOUnited States$587M+87%+1,007%-195%18.3×n/an/a
Xvivo Perfusion XVIVO.STSweden$611M-32%+18%12%6.3×35.9%+35.2%
Jiangsu Hanvo Safety Product 300952.SZChina$575M-38%+6%8%3.3×n/an/a
Beijing Chunlizhengda Medical Instruments 688236.SSChina$618M-27%-13%31%2.1×-8.5%+2.2%
Pacific Biosciences of California PACBUnited States$573M+54%+4%-98%6.7×n/an/a
Wuhan Huakang Century Clean Technology 301235.SZChina$563M-57%+28%7%1.6×n/an/a
SunMax Biotechnology 4728.TWOTaiwan$630M0%+19%51%8.3×-2.6%+18.8%
Cowealth Medical China 603122.SSChina$562M-34%-18%-5%5.9×n/an/a
AK Medical 1789.HKHong Kong$642M-23%+16%26%2.1×-11.5%+6.7%
Contec Medical Systems 300869.SZChina$547M-26%-2%-16%5.5×15.0%-19.8%
Zhejiang Gongdong Medical Technology 605369.SSChina$542M-21%+6%9%2.6×10.2%+6.5%
QuidelOrtho QDELUnited States$657M-20%-5%-2%1.4×n/an/a
Synektik SNT.WAPoland$662M+10%+32%24%2.9×0.2%+47.5%

Questions

Which companies are Sahajanand Medical Technologies's closest peers?
The cockpit's peer set: vVARDIS (VVVV), Sight Sciences (SGHT), Medistim (MEDI.OL), Tactile Systems Technology (TCMD), Nanosonics (NAN.AX), Hangzhou AGS MedTech (688581.SS), Ningbo David Medical Device (300314.SZ), Orchestra BioMed (OBIO).

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.